Results 71 to 80 of about 13,189,470 (203)

Antifungal Agents for the Treatment of Systemic Fungal Infections in Children

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2010
Traditionally, the mainstay of systemic antifungal therapy has been amphotericin B deoxycholate (conventional amphotericin B). Newer agents have been developed to fulfill special niches and to compete with conventional amphotericin B by virtue of having ...
UD Allen
doaj   +1 more source

Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice

open access: yesBrazilian Journal of Infectious Diseases, 2016
A natural and biocompatible fibrin microsphere is one of the most promising dual delivery vehicle as compared to other traditionally designed delivery modalities.
Azmat Ali Khan   +3 more
doaj   +1 more source

Molecular Modeling Studies on Amphotericin B and its Complex with Phospholipid,

open access: yes, 1995
Molecular dynamics simulation studies on polyene antifungal antibiotic amphotericin B, its head-to-tail dimeric structure and lipid - amphotericin B complex demonstrate interesting features of the flexibilities within the molecule and define the optimal ...
Easwaran, KRK   +4 more
core  

Proportion of patients achieving initial and definitive cure after treatment with amphotericin B emulsion and liposomal amphotericin B (mITT population).

open access: yes, 2014
Data are n (%); mITT = modified Intent-to-Treat; CI = confidence interval.Proportion of patients achieving initial and definitive cure after treatment with amphotericin B emulsion and liposomal amphotericin B (mITT population).
Tara Kant Jha (631050)   +9 more
core   +1 more source

Oral amphotericin B: The journey from bench to market [PDF]

open access: yes, 2017
Since the 1950s, amphotericin B (AmB) has been used in the clinical practice to treat systemic fungal infections and leishmaniasis, a neglected parasitic disease that can be fatal if left untreated.
Dolores R. Serrano   +3 more
core   +1 more source

Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo

open access: yesRevista do Instituto de Medicina Tropical de São Paulo
Chromoblastomycosis is a chronic fungal infection. Itraconazole and terbinafine are the most recommended antifungal drugs for chromoblastomycosis, while amphotericin B is not usually recommended.
Jing Zhang   +7 more
doaj   +1 more source

Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study

open access: yes, 2017
Waled Mahdy Nada, Mahmoud A Al Aswad, Wael M El-Haig Ophthalmology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt Purpose: To evaluate the efficacy of combination therapy of a single intrastromal injection of amphotericin B and ...
El-Haig WM, Al Aswad MA, Nada WM
core  

Amphotericin B and the blood-brain barrier to methotrexate

open access: yes, 1982
The permeability of the blood-brain barrier (BBB) to methotrexate, Na+, and Cl- was studied in rats treated with the membrane-active antifungal agent amphotericin B. Enhancement of brain uptake of methotrexate was expected as amphotericin B increases the
Barry, D I, Paulson, O B
core   +1 more source

Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome):aerosol characteristics and in-vivo amphotericin B deposition in rats

open access: yes, 2000
In the treatment or prophylaxis of invasive pulmonary aspergillosis, it may be attractive to administer the antifungal agent amphotericin directly to the pulmonary route via aerosol inhalation.
Vulto, A G; id_orcid   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy